Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Update

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) was the target of a significant growth in short interest in the month of September. As of September 15th, there was short interest totaling 33,174 shares, a growth of 219.3% from the August 31st total of 10,391 shares. Based on an average daily trading volume, of 1,979,498 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are short sold.

Advanced Medical Isotope Stock Down 1.7%

RDGL stock traded down $0.00 during midday trading on Friday, reaching $0.05. The company’s stock had a trading volume of 203,783 shares, compared to its average volume of 778,150. The business’s 50-day simple moving average is $0.05 and its 200-day simple moving average is $0.07. Advanced Medical Isotope has a 52 week low of $0.04 and a 52 week high of $0.12. The stock has a market cap of $22.67 million, a PE ratio of -4.59 and a beta of -0.72.

About Advanced Medical Isotope

Advanced Medical Isotope Corporation is a medical technology company developing targeted radiation products for cancer treatment. Its primary product candidate is RadioGel™, an injectable brachytherapy device designed to deliver yttrium-90 radiation directly to solid tumors. The company’s approach is intended to provide localized treatment while limiting radiation exposure to surrounding healthy tissue.

RadioGel is being developed for potential use in treating tumors that may be difficult to address with conventional external-beam radiation or surgery.